Precigen, Inc. (PGEN)

PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know

Comparing PTC Therapeutics (NASDAQ:PTCT) and Precigen (NASDAQ:PGEN)

4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike

Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock?

PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?

Precigen: The FDA's Platform Technology Designation And The Institutional Crossover Effect

Can PGEN's AdenoVerse Pipeline Create Growth Beyond Papzimeos?

Precigen (NASDAQ:PGEN) Hits New 1-Year High – Time to Buy?

Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform

Head-To-Head Comparison: Precigen (NASDAQ:PGEN) and Celldex Therapeutics (NASDAQ:CLDX)

Precigen Gains 43% in 3 Months: Is It an Indication to Buy the Stock?

Can Papzimeos Drive Precigen's Growth Through the Rest of 2026?

Legal & General Group Plc Takes $730,000 Position in Precigen, Inc. $PGEN

Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen

5 Biotech Stocks Worth Adding to Your Portfolio Now

Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers

Reasons Why Investors Should Consider Betting on PGEN Stock

Are You Looking for a Top Momentum Pick? Why Precigen, Inc. (PGEN) is a Great Choice

Precigen: Has To Grow Into Its Valuation

Precigen: 'Strong Buy' Papzimeos Cash-Flow Breakeven In '26, PRGN-2009 Advancement